Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-24-020784
Filing Date
2024-05-20
Accepted
2024-05-20 17:27:11
Documents
1
Effectiveness Date
2024-05-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12304
  Complete submission text file 0001493152-24-020784.txt   13491
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-513789 | Film No.: 24965976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)